| On the origin of leprosy M Monot, N Honoré, T Garnier, R Araoz, JY Coppée, C Lacroix, S Sow, ... Science 308 (5724), 1040-1042, 2005 | 490 | 2005 |
| Neuropathic pain in leprosy patients P Stump, R Baccarelli, L Marciano, JRP Lauris, MJ Teixeira, S Ura, ... International journal of leprosy and other mycobacterial diseases 72 (2 …, 2004 | 60 | 2004 |
| Toll-like receptor 1 N248S single-nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection C de Sales Marques, VN Brito-de-Souza, LTA Guerreiro, JH Martins, ... The Journal of infectious diseases 208 (1), 120-129, 2013 | 54 | 2013 |
| Cirurgia reparadora e reabilitação em hanseníase F Duerksen, M Virmond Bauru: ALM Internacional. Centro de Estudos Dr. Reinaldo Quagliato …, 1997 | 42 | 1997 |
| Prevenção de incapacidades na hanseníase: uma análise crítica M Virmond, H Vieth Medicina (Ribeirão Preto. Online) 30 (3), 358-363, 1997 | 38 | 1997 |
| NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians C Sales-Marques, H Salomão, VM Fava, LE Alvarado-Arnez, EP Amaral, ... Human genetics 133 (12), 1525-1532, 2014 | 37 | 2014 |
| Multidrug therapy for leprosy: a game changer on the path to elimination CS Smith, A Aerts, P Saunderson, J Kawuma, E Kita, M Virmond The Lancet Infectious Diseases 17 (9), e293-e297, 2017 | 35 | 2017 |
| A randomized clinical trial of oral steroids for ulnar neuropathy in type 1 and type 2 leprosy reactions JA Garbino, MCL Virmond, S Ura, MH Salgado, B Naafs Arquivos de Neuro-psiquiatria 66 (4), 861-867, 2008 | 33 | 2008 |
| Hanseníase: episódios reacionais NT Foss, CS Souza, IMB Goulart, HS Gonçalves, M Virmond Projeto diretrizes, 2005 | 31 | 2005 |
| A hanseníase como doença de baixa prevalência M Virmond Hansen int 20 (2), 27-35, 1995 | 31 | 1995 |
| Criação de banco de dados para sustentação da pós-eliminação em hanseníase VDA Paschoal, SMT Nardi, MRCO Cury, C Lombardi, MCL Virmond, ... Ciência & Saúde Coletiva 16, 1201-1210, 2011 | 30 | 2011 |
| Factors contributing to the delay in diagnosis and continued transmission of leprosy in Brazil–an explorative, quantitative, questionnaire based study M Henry, N GalAn, K Teasdale, R Prado, H Amar, MS Rays, L Roberts, ... PLoS neglected tropical diseases 10 (3), e0004542, 2016 | 29 | 2016 |
| Hanseníase: diagnóstico e tratamento da neuropatia JA Garbino, JA Nery, M Virmond, PRN Stump, R Baccarelli, JR Marques Projeto Diretrizes, Associacao Medica Brasileira e Conselho Federal de …, 2003 | 29 | 2003 |
| Primary neural leprosy: systematic review JA Garbino, W Marques Jr, JA Barreto, CO Heise, MMJ Rodrigues, ... Arquivos de neuro-psiquiatria 71 (6), 397-404, 2013 | 26 | 2013 |
| Alguns apontamentos sobre a história da prevenção de incapacidades e reabilitação em hanseníase no Brasil MCL Virmond Hansenologia Internationalis (Online) 33 (2), 13-18, 2008 | 26 | 2008 |
| Molecular drug susceptibility testing and genotyping of Mycobacterium leprae strains from South America P Singh, P Busso, A Paniz-Mondolfi, N Aranzazu, M Monot, N Honore, ... Antimicrobial agents and chemotherapy 55 (6), 2971-2973, 2011 | 23 | 2011 |
| The nose in leprosy: immunohistology of the nasal mucosa WJ Fokkens, GJN Trenite, M Virmond, AK Jan, VLG Andrade, ... International journal of leprosy and other mycobacterial diseases 66, 328-339, 1998 | 23 | 1998 |
| Neurophysiological patterns of ulnar nerve neuropathy in leprosy reactions JA Garbino, B Naafs, S Ura, MH Salgado, M Virmond Leprosy review 81 (3), 206, 2010 | 21 | 2010 |
| Neuropathic pain in leprosy I Raicher, PRNAG Stump, R Baccarelli, LHSC Marciano, S Ura, ... Clinics in dermatology 34 (1), 59-65, 2016 | 20 | 2016 |
| Time to define leprosy elimination as zero leprosy transmission? CS Smith, A Aerts, E Kita, M Virmond The Lancet. Infectious diseases 16 (4), 398, 2016 | 18 | 2016 |
